Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quince Therapeutics, Inc.

1.17
-0.0200-1.68%
Post-market: 1.170.00000.00%19:58 EDT
Volume:191.24K
Turnover:228.17K
Market Cap:53.20M
PE:-0.84
High:1.21
Open:1.20
Low:1.16
Close:1.19
Loading ...

Press Release: Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

Dow Jones
·
25 Mar

Quince Therapeutics Initiated at Outperform by Oppenheimer

Dow Jones
·
24 Mar

Oppenheimer Initiates Quince Therapeutics at Outperform

MT Newswires Live
·
24 Mar

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Simply Wall St.
·
05 Mar

Quince Therapeutics: Gets Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia

THOMSON REUTERS
·
05 Feb

BRIEF-Quince Therapeutics Appoints William Whitehouse To Scientific Advisory Board

Reuters
·
24 Jan

Quince Therapeutics Appoints Renowned Pediatric Neurologist DR. William Whitehouse to Scientific Advisory Board

THOMSON REUTERS
·
24 Jan

Quince Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Jan

Spotlight On US Penny Stocks For January 2025

Simply Wall St.
·
02 Jan

Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours

MT Newswires Live
·
19 Dec 2024

BRIEF-Quince Therapeutics Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing

Reuters
·
19 Dec 2024

Quince Therapeutics: Sales Agreement Prospectus Covers Offering of up to $75.0 Mln of Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
19 Dec 2024

Quince Therapeutics: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
19 Dec 2024

Quince Therapeutics initiated with a Buy at Brookline

TIPRANKS
·
18 Dec 2024

Quince Therapeutics: Promising Investment with EryDex’s Innovative Treatment and Strong Financial Position

TIPRANKS
·
18 Dec 2024